| Residents, No. (%) | |||
---|---|---|---|---|
Long-staya with advanced illnessb | Short-staya with advanced illnessb | |||
Baseline Characteristics | Intervention (n = 1485) | Control (n = 2417) | Intervention (n = 873) | Control (n = 1342) |
Age, mean(SD), y | 84.0 (8.4) | 83.0 (8.4) | 82.0 (8.4) | 81.8 (8.0) |
Female sex | 1035 (69.7) | 1705 (70.5) | 467 (53.5) | 739 (55.1) |
Race / Ethnicity | ||||
 White | 1367 (92.1) | 2097 (86.8) | 819 (93.8) | 1173 (87.4) |
 Black | 88 (5.9) | 205 (8.5) | 31 (3.6) | 109 (8.1) |
 Hispanic | 20 (1.3) | 77 (3.2) | 5 (0.6) | 40 (3.0) |
 Asian | 2 (0.1) | 7 (0.3) | 5 (0.6) | 3 (0.2) |
 Otherc | 6 (0.4) | 27 (1.1) | 6 (0.7) | 10 (0.7) |
 Unknown | 2 (0.1) | 4 (0.2) | 7 (0.8) | 7 (0.5) |
Advanced dementia | 963 (64.8) | 1630 (67.4) | 368 (42.2) | 660 (49.2) |
Advanced CHF or COPDb | 572 (38.5) | 857 (35.5) | 522 (59.8) | 704 (52.5) |
ADL score, mean(SD)d | 21.6 (3.9) | 21.5 (4.0) | 20.6 (3.5) | 21.0 (3.5) |
MRS3 score, mean(SD)e | 7.7 (2.8) | 7.5 (2.7) | 7.8 (2.6) | 7.6 (2.7) |
Days of follow-up, mean(SD) | 286.3(124.8) | 283.2(126.3) | 84.8(30.2) | 87.0(28.4) |